GB9119704D0 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
GB9119704D0
GB9119704D0 GB919119704A GB9119704A GB9119704D0 GB 9119704 D0 GB9119704 D0 GB 9119704D0 GB 919119704 A GB919119704 A GB 919119704A GB 9119704 A GB9119704 A GB 9119704A GB 9119704 D0 GB9119704 D0 GB 9119704D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic agents
therapeutic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB919119704A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority to GB919119704A priority Critical patent/GB9119704D0/en
Publication of GB9119704D0 publication Critical patent/GB9119704D0/en
Application status is Pending legal-status Critical

Links

GB919119704A 1991-09-14 1991-09-14 Therapeutic agents Pending GB9119704D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB919119704A GB9119704D0 (en) 1991-09-14 1991-09-14 Therapeutic agents

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919119704A GB9119704D0 (en) 1991-09-14 1991-09-14 Therapeutic agents
PCT/EP1992/002068 WO1993006104A1 (en) 1991-09-14 1992-09-04 Pyrazolopyrimidinone antianginal agents
PT10086292A PT100862A (en) 1991-09-14 1992-09-11 Anti-surgical agents of pyrazolopyrimidones and process for their preparation

Publications (1)

Publication Number Publication Date
GB9119704D0 true GB9119704D0 (en) 1991-10-30

Family

ID=10701447

Family Applications (1)

Application Number Title Priority Date Filing Date
GB919119704A Pending GB9119704D0 (en) 1991-09-14 1991-09-14 Therapeutic agents

Country Status (3)

Country Link
GB (1) GB9119704D0 (en)
PT (1) PT100862A (en)
WO (1) WO1993006104A1 (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5294612A (en) * 1992-03-30 1994-03-15 Sterling Winthrop Inc. 6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-ones and compositions and method of use thereof
GB9423911D0 (en) * 1994-11-26 1995-01-11 Pfizer Ltd Therapeutic agents
GB9423910D0 (en) 1994-11-26 1995-01-11 Pfizer Ltd Therapeutic agents
DE19518082A1 (en) * 1995-05-17 1996-11-21 Merck Patent Gmbh 4 (-Arylaminomethylen) -2,4-dihydropyrazol-3-one
US6472425B1 (en) 1997-10-31 2002-10-29 Nitromed, Inc. Methods for treating female sexual dysfunctions
US5958926A (en) * 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
EA004315B1 (en) 1997-04-25 2004-02-26 Пфайзер Инк. New sulfonilbenzoynye acid and a process for preparing 4-benzamidopirazolo-5-carboxamides from their use
GB9722520D0 (en) 1997-10-24 1997-12-24 Pfizer Ltd Compounds
EP2295436A1 (en) * 1997-11-12 2011-03-16 Bayer Schering Pharma AG 2-Phenyl-subsitituted Imidazotriazinones as Phosphodiesterase V inhibitors
ES2242124T3 (en) * 1998-04-20 2005-11-01 Pfizer Inc. Acid derivatives pyridin-3-carboxylic acid and their use as intermediates.
GB9823103D0 (en) 1998-10-23 1998-12-16 Pfizer Ltd Pharmaceutically active compounds
GB9823101D0 (en) 1998-10-23 1998-12-16 Pfizer Ltd Pharmaceutically active compounds
GB9823102D0 (en) 1998-10-23 1998-12-16 Pfizer Ltd Pharmaceutically active compounds
KR100353014B1 (en) * 1998-11-11 2002-09-18 동아제약 주식회사 Pyrazolopyrimidinone derivatives for the treatment of impotence
US6225315B1 (en) 1998-11-30 2001-05-01 Pfizer Inc Method of treating nitrate-induced tolerance
GB9910378D0 (en) * 1999-05-05 1999-06-30 Smithkline Beecham Plc Novel compounds
US7235625B2 (en) 1999-06-29 2007-06-26 Palatin Technologies, Inc. Multiple agent therapy for sexual dysfunction
AP200202455A0 (en) 1999-10-11 2002-06-30 Pfizer 5-(2-Substituted-5-hetreocyclysulphonyl pyrid-3-yl)-dihydropyrazoloÄ4,3-dÜpyrimidin-7ones as phosphidiesterase inhibitors
TWI265925B (en) 1999-10-11 2006-11-11 Pfizer Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them
EP1261609B1 (en) 1999-12-24 2004-11-03 Bayer HealthCare AG Triazolotriazinones and the use thereof
MXPA02010322A (en) * 2000-04-19 2004-09-10 Univ Johns Hopkins Methods for prevention and treatment of gastrointestinal disorders.
KR100377782B1 (en) 2000-06-23 2003-03-29 동아제약 주식회사 A process for preparing pyrazolopyrimidinone derivatives for the treatment of impotence
US6548508B2 (en) 2000-10-20 2003-04-15 Pfizer, Inc. Use of PDE V inhibitors for improved fecundity in mammals
US7335680B2 (en) 2001-12-20 2008-02-26 Laboratoires Serono Sa Pyrrolidine derivatives as prostaglandin modulators
GB0202282D0 (en) 2002-01-31 2002-03-20 Pfizer Ltd Treatment of male sexual dysfunction
DE10232113A1 (en) 2002-07-16 2004-01-29 Bayer Ag Vardenafil hydrochloride trihydrate medicaments containing
GB0219961D0 (en) 2002-08-28 2002-10-02 Pfizer Ltd Oxytocin inhibitors
US7323462B2 (en) 2002-12-10 2008-01-29 Pfizer Inc. Morpholine dopamine agonists
NZ542097A (en) 2003-04-29 2008-12-24 Pfizer Ltd 5,7-Diaminopyrazolo[4,3-d]pyrimidines useful in the treatment of hypertension
US7572799B2 (en) 2003-11-24 2009-08-11 Pfizer Inc Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
EP1742950B1 (en) 2004-04-07 2008-12-17 Pfizer Limited Pyrazolo[4,3-d] pyrimidines
DE102005009240A1 (en) 2005-03-01 2006-09-07 Bayer Healthcare Ag Dosage forms with improved pharmacokinetic properties
AU2006245416B2 (en) 2005-05-12 2012-02-23 Pfizer Inc. Anhydrous crystalline forms of N-[1-(2-ethoxyethyl)-5-(N-ethyl-N-methylamino)-7-(4-methylpyridin-2-yl-amino)-1H-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide
CN1966506A (en) * 2005-11-17 2007-05-23 上海特化医药科技有限公司 Pyrromonazole pyrimidinone derivatives, method of producing them and use thereof
US9402877B2 (en) 2011-11-04 2016-08-02 Xion Pharmaceuticals Corporation Methods and compositions for oral administration of melanocortin receptor agonist compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666908A (en) * 1985-04-05 1987-05-19 Warner-Lambert Company 5-Substituted pyrazolo[4,3-d]pyrimidine-7-ones and methods of use
GB9013750D0 (en) * 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
PT100862A (en) 1993-11-30
WO1993006104A1 (en) 1993-04-01

Similar Documents

Publication Publication Date Title
US5529766C1 (en) Contrast agents
GB8820844D0 (en) Therapeutic agents
PL297979A1 (en) Therapeutic agent coupled with asialoglycoproteine
IE921799A1 (en) Therapeutic preparations
IL102626D0 (en) Therapeutic amides
GB9311920D0 (en) Therapeutic agents
GB9322976D0 (en) Therapeutic agents
GB9226729D0 (en) Therapeutic combination
GB9315808D0 (en) Therapeutic agents
GB9306578D0 (en) Therapeutic agents
GB9300051D0 (en) Therapeutic agents
GB9218322D0 (en) Therapeutic agents
GB9210393D0 (en) Therapeutic agents
GB9013750D0 (en) Therapeutic agents
GB9222486D0 (en) Therapeutic agents
GB9220286D0 (en) Therapeutic agents
GB9222262D0 (en) Therapeutic agents
GB9211193D0 (en) Therapeutic agents
IL101818D0 (en) Therapeutic agent
GB9216911D0 (en) Therapeutic agents
GB9213623D0 (en) Therapeutic agents
GB9022785D0 (en) Therapeutic agents
GB9226581D0 (en) Therapeutic agents
GB9318431D0 (en) Therapeutic agents
GB9215527D0 (en) Therapeutic agents